April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Derivation of traceable and transplantable photoreceptors from mouse embryonic stem cells
Author Affiliations & Notes
  • Sarah Decembrini
    Unit of Gene Therapy & Stem Cell Biology, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
  • Ute Koch
    École Polytechnique Fédérale de Lausanne, Institut Suisse de Recherche Expérimentale sur le Cancer, Lausanne, Switzerland
  • Freddy Radtke
    École Polytechnique Fédérale de Lausanne, Institut Suisse de Recherche Expérimentale sur le Cancer, Lausanne, Switzerland
  • Alexandre P Moulin
    Eye Pathology Laboratory, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
  • Yvan Arsenijevic
    Unit of Gene Therapy & Stem Cell Biology, Jules-Gonin Eye Hospital, University of Lausanne, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships Sarah Decembrini, None; Ute Koch, None; Freddy Radtke, None; Alexandre Moulin, None; Yvan Arsenijevic, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 1115. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah Decembrini, Ute Koch, Freddy Radtke, Alexandre P Moulin, Yvan Arsenijevic; Derivation of traceable and transplantable photoreceptors from mouse embryonic stem cells. Invest. Ophthalmol. Vis. Sci. 2014;55(13):1115.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Retinal degenerative diseases resulting in the loss of photoreceptors are a major cause of blindness. Recently, different groups validated the possibility to reactivate dormant retinal circuits of degenerating retinas using retinal prosthesis, gene and cell replacement therapy. Photoreceptor replacement therapy may be feasible since transplanted photoreceptors, collected directly from the developing or the adult retina, have been shown to restore some visual function in mice affected by retinal degeneration. Because the developing retina is not a suitable source of renewable photoreceptors, we focused on embryonic stem cells (ESC) for their capacity to generate retinal progenitors and photoreceptor cells in vitro.

Methods: In this study, we derived a new transgenic ESC line in which the reporter gene, the Crx-GFP transgene, is expressed in both post-mitotic immature and mature photoreceptors, and assessed the extent to which this protocol recapitulates photoreceptor development in vitro.

Results: Various oxygen concentrations were tested at different development stages to improve photoreceptor production. As observed during the retinogenesis, the optimized 3D-retina induction protocol allows the production of GFP-positive photoreceptors between 12 and 14 days of culture which reach the peak of birth between day 18 and 20 of culture. Similarly the intensity of the GFP signal and their alignment increase over time. We observed that hyperoxic condition improved photoreceptor survival only when present since photoreceptor differentiation onset. Up to ten layers of photoreceptors can be formed in each in vitro-generated retinas. In addition we proved that transplantation of ESC-derived photoreceptors is feasible. No appearance of tumour formation was detected after transplantation of sorted photoreceptor cells. Many Crx-GFP-positive cells show the presence of outer-segments, ribbon synapses, and light signal transduction pathway proteins.

Conclusions: These experiments show the feasibility to reliably generate a large quantity of integration-competent photoreceptors from ESCs. A further characterization of the transplanted photoreceptors to reveal their capacity to mediate light stimuli is underway.

Keywords: 648 photoreceptors • 741 transplantation • 688 retina  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×